HIV/AIDS-Associated Infection
Cotrimoxazole prophylaxis reduces morbidity/mortality among HIV- family members
Published in Medical Letter on the CDC and FDA, September 25th, 2005
According to a recently published report from Uganda, "The effect of cotrimoxazole prophylaxis taken by persons with HIV on community health and antimicrobial resistance is unknown." The "effect of cotrimoxazole prophylaxis taken by persons with HIV on morbidity, mortality, and antimicrobial resistance of diarrheal pathogens infecting their HIV-negative family members" was assessed in a prospective cohort in rural Uganda.
"A total of 879 persons with HIV and 2771 HIV-negative family members received weekly home-visits. After 5...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Antimicrobial Resistance
Cefoxitin test correlates with mecA presence in Staphylococcus - Environmental Health
Acute illnesses associated with pesticide exposure at schools reported - Immunology
CD4-CD8- T cells control intracellular bacterial infections - Immunotoxicity
Biomarkers assess potential developmental immunotoxicity in children - Smallpox Vaccine Development
Monitoring health care workers after smallpox vaccination described - Alcohol Use
Acamprosate for treatment of alcohol dependence reviewed - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
